These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22851573)

  • 1. The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment.
    Xu J; Wu W; Zhang L; Dorset-Martin W; Morris MW; Mitchell ME; Liechty KW
    Diabetes; 2012 Nov; 61(11):2906-12. PubMed ID: 22851573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-146a Deficiency Delays Wound Healing in Normal and Diabetic Mice.
    Bi X; Zhou L; Liu Y; Gu J; Mi QS
    Adv Wound Care (New Rochelle); 2022 Jan; 11(1):19-27. PubMed ID: 33554730
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of microRNA-15b in the impaired angiogenesis in diabetic wounds.
    Xu J; Zgheib C; Hu J; Wu W; Zhang L; Liechty KW
    Wound Repair Regen; 2014; 22(5):671-7. PubMed ID: 25059098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease.
    Ramkaran P; Khan S; Phulukdaree A; Moodley D; Chuturgoon AA
    Cell Biochem Biophys; 2014 Mar; 68(2):259-66. PubMed ID: 23794009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone mesenchymal stem cell-derived exosomal miR-146a-5p promotes diabetic wound healing in mice via macrophage M1/M2 polarization.
    Zhou X; Ye C; Jiang L; Zhu X; Zhou F; Xia M; Chen Y
    Mol Cell Endocrinol; 2024 Jan; 579():112089. PubMed ID: 37863468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
    Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Cerium Oxide Nanoparticles Conjugated with MicroRNA-146a to Correct the Diabetic Wound Healing Impairment.
    Zgheib C; Hilton SA; Dewberry LC; Hodges MM; Ghatak S; Xu J; Singh S; Roy S; Sen CK; Seal S; Liechty KW
    J Am Coll Surg; 2019 Jan; 228(1):107-115. PubMed ID: 30359833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes.
    Feng B; Chen S; Gordon AD; Chakrabarti S
    J Mol Cell Cardiol; 2017 Apr; 105():70-76. PubMed ID: 28279663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells.
    Lv F; Huang Y; Lv W; Yang L; Li F; Fan J; Sun J
    Med Sci Monit; 2017 Feb; 23():659-664. PubMed ID: 28161709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.
    Chan YC; Roy S; Khanna S; Sen CK
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1372-82. PubMed ID: 22499991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition.
    Kamali K; Korjan ES; Eftekhar E; Malekzadeh K; Soufi FG
    Bratisl Lek Listy; 2016; 117(7):376-80. PubMed ID: 27546538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
    Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
    J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200b-3p accelerates diabetic wound healing through anti-inflammatory and pro-angiogenic effects.
    Wang HJ; Sin CH; Yang SH; Hsueh HM; Lo WY
    Biochem Biophys Res Commun; 2024 Oct; 731():150388. PubMed ID: 39024974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy.
    Wang L; Chopp M; Szalad A; Zhang Y; Wang X; Zhang RL; Liu XS; Jia L; Zhang ZG
    Neuroscience; 2014 Feb; 259():155-63. PubMed ID: 24316060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Synthetic Curcuminoid Analog, (2
    Huang J; Fu J; Liu B; Wang R; You T
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32092902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146a promotes M2 macrophage polarization and accelerates diabetic wound healing by inhibiting the TLR4/NF-κB axis.
    Peng X; He F; Mao Y; Lin Y; Fang J; Chen Y; Sun Z; Zhuo Y; Jiang J
    J Mol Endocrinol; 2022 May; 69(2):315-327. PubMed ID: 35604113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin β4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway.
    Santra M; Zhang ZG; Yang J; Santra S; Santra S; Chopp M; Morris DC
    J Biol Chem; 2014 Jul; 289(28):19508-18. PubMed ID: 24828499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells-derived MFG-E8 accelerates diabetic cutaneous wound healing.
    Uchiyama A; Motegi SI; Sekiguchi A; Fujiwara C; Perera B; Ogino S; Yokoyama Y; Ishikawa O
    J Dermatol Sci; 2017 Jun; 86(3):187-197. PubMed ID: 28302404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas.
    Winkler MA; Dib C; Ljubimov AV; Saghizadeh M
    PLoS One; 2014; 9(12):e114692. PubMed ID: 25490205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
    Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
    J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.